cache/45e11f21ac4056d700c60074dcbc5de1d5c024d455e2bd67a6b5ff5d435e1ba1

COM:ALKEUSPHARMA

Alkeus Pharmaceuticals Inc

  • Privately Held

Alkeus Pharmaceuticals Inc develops Gildeuretinol (ALK-001), an investigational therapy aimed at addressing the underlying mechanism of Stargardt disease, a genetic cause of blindness.

investor of